It is a quietly common story wherever people rely on GPCR antibodies, and it is where our conversation For a class of reagents as demanding as GPCR antibodies, that humility turns out to be the point. Why GPCR antibodies punish you early Good GPCR antibodies are notoriously hard to make, and the reasons behaves the same way years from now, without the batch-to-batch drift that has quietly undermined so much drug discovery.

Welcome GPCR Fans,   In GPCR-targeted drug discovery, precision isn’t optional—it’s a requirement. GPCR Premium Members this week gain curated, early access to: Industry insights : GPCRs and mRNA in drug Upcoming events : Lab-in-the-Loop AI-powered hit discovery (July 29); 5th Transatlantic GPCR Symposium At this international meeting, leaders shared next-gen strategies shaping modern drug discovery: Prof Scientists, drug discovery teams, and pharmacologists who need curated, career-relevant updates.

Drugs like Ozempic will change the world GPCR Events, Meetings, and Webinars November 5 - 7, 2024 | 16th Forum Conference November 26 - 28, 2024 | GPCRs-Targeted Drug Discovery Summit Europe NEW December Drug Discovery NEW February 15 - 19, 2025 | BPS 2025 NEW February 16 - 21, 2025 | Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery NEW March 12 - 14, 2025 | NextGen Biomed 2025 Discovery Chemistry NEW   April 24 - 27, 2025 | American Physiology Summit 2025 NEW April 25 - 30, 2025

A rational drug discovery campaign hinges on a deep understanding of how distinct molecules interact While these structural techniques offer significant advantages in drug discovery, no single method can However, several challenges have limited the use of mutagenesis in drug discovery. In summary, mutagenesis can be a critical tool in drug discovery, particularly for studying GPCRs. discovery.

Drug discovery programs rarely fail because an assay produced poor data. decisions Drug Discovery Pharmacology Principles in Action Drug discovery pharmacology principles revolve Chemists Make The Drugs Drug discovery is fundamentally a team sport . Failure Is the Real Curriculum Drug discovery carries a difficult truth: most programs fail. Why Terry’s Corner Drug discovery pharmacology principles rarely appear in textbooks the way they are

Selectivity is one of the most overused—and misunderstood—terms in drug discovery. selectivity and signaling bias Quantifying Receptor Selectivity Requires Canceling the Cell In early discovery It prevents discovery teams from advancing compounds based on artifacts of expression systems rather Comparing Full and Partial Agonists Discovery programs rarely enjoy the simplicity of comparing two full But during discovery, pathway dissection can clarify mechanism and reveal hidden liabilities.

Watch Episode 170 What We’re Missing in Pain Research In GPCR drug discovery, receptors typically steal explicitly interested in GPCR signaling... but the thing about GPCRs... is you always kind of end up landing at a GPCR as a major target." Serafini highlighted that in modern pain drug development, the field has remained too focused on ion Takeaway Forget what you think you know about GPCR drug targets.

The future of discovery will belong to scientists who know how to build the right partnerships and stay was a set of chemical probes that finally allowed researchers to visualize where receptors exist, how drugs No one person can be excellent at all of it — and pretending otherwise slows discovery. It is the only path to meaningful discovery. And it’s not just about capability. pathways Creating chemical tools that finally show how drugs reach their targets These aren’t solo-lab

Upcoming events:   Preview of Discovery on Target 2025 (Boston, Sept 24‑25), including GPCR‑Track breakout Snapshot of roles spanning PhD entry points to senior translational pharmacology—Protein Expression, Drug Discovery Scientist, and Staff Scientist in Molecular Pharmacology—curated with notes on fit, skill See the full guide and example ligands ➤ Discovery on Target 2025 Speaker Spotlight: Solubilization, GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

GPCR and Revvity. If you’re in GPCR discovery or biotech R&D, this is a masterclass in turning deep science into scalable Timeline: The Road to pHSense → Initial lanthanide probe design with Durham University (chemistry) → Discovery It’s a strategic tool for decoding GPCR behavior in drug discovery and systems biology. GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.

April 29, and the GPCRs Drug Discovery Summit April 28-30. iPSC-Derived GPCR Models: Beyond HEK293 for allosteric binding modes, and why establishing that distinction early carries immense practical value for drug discovery programs at any stage. GPCR at the GPCRs Targeted Drug Discovery Summit — Boston, April 28-30 The GPCRs Targeted Drug Discovery GPCR University Learner About Dr. GPCR Dr.

Read fast, apply faster, and stay ahead in GPCR drug discovery with evidence-based insights—no hype, GPCR Forum to Biophysics; plus targeted summits for discovery teams planning 2025–2026. Drug Discovery In neuroscience drug discovery, the right tool  can be just as critical as the right discovery ➤ Why Dr. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

structural biology and drug discovery at opioid and galanin receptors. Joseph Kim: Structural Biology and Drug Discovery at GPCRs Cryo-EM has transformed how we visualize receptor–ligand interactions — and with it, how we think about drug discovery at GPCRs. Microcircuits in Drug Discovery  →   Read DiscoverX article A2A Fluorescent Competitive Binding with discovery.

of the prime targets for marketed drugs. While traditional drug discovery programs have focused on the development of ligands targeting the binding structure-based discovery and development of allosteric modulators as novel therapeutic candidates. current strategies for the identification of allosteric sites as well as ligand-based and structure-based drug discovery and design."

drug discovery. Superluminal Medicines: AI/ML Meets GPCR Pharmacology As Ajay continued to explore how GPCR signaling could be leveraged for therapeutic innovation, he saw a gap in the drug discovery landscape. The company’s goal is to model receptor dynamics — including biased signaling — to predict drug behavior early career redirection to startup setbacks, each step has added new layers to his thinking about drug

Broichhagen aka JB, the goal was bold and elegant: Create a photo-switchable ligand to remotely control GPCR They had a tool that did bind the GPCR… but not in the light-controlled way they wanted. For metabolic GPCRs (like GLP-1 and GIP receptors): Drug efficacy depends on which cells express the activity in live systems The success wasn’t in the discovery. Clarify brain vs. peripheral contributions to metabolic therapy Guide how next-generation incretin drugs

Introduction G protein-coupled receptors (GPCRs) remain one of the most important classes of drug targets of different calcium readout technologies How to select the most appropriate assay format for drug discovery GPCR Calcium Assay Cell Models from Eurofins DiscoverX® Selecting the right cell model can be just as calcium mobilization one of the most commonly used functional readouts in drug discovery. biology and accelerate drug discovery programs.

Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery G-protein-coupled receptors GPCR dimers are therefore emerging drug targets in different therapeutic areas including depression, In this study Xin Cai et al. highlight the importance of GPCR dimers in drug discovery referring to important What is the potential of targeting GPCR dimer interface in drug discovery? dimerization while accelerating drug discovery targeting GPCR dimers.

The Cell Surface Is Only Part of the Story For decades, GPCR pharmacology centered on events at the cell This framework shaped how assays were designed, how drug candidates were profiled, and how efficacy was Work on receptors such as GLP-1R and MC4R has demonstrated that internalized GPCRs can continue to signal Measuring GPCR Internalization: Assay Strategies Beyond Imaging The classical approach to detecting internalization Terry Kenakin’s session on measuring GPCR internalization walks through the assay logic, the mechanistic

Historically, drug discovery efforts targeting GPCRs focused on G-protein-dependent signaling pathways discovery. drug discovery (Eishingdrelo & Kongsamut, 2013). Minireview: targeting GPCR activated ERK pathways for drug discovery. Biased receptor signaling in drug discovery. Pharmacological Reviews, 71(2), 267-315.

High-content screening (HCS) has become a cornerstone in GPCR and phenotypic drug discovery, enabling In this blog, you’ll learn:  How HCS works and why it is increasingly central to GPCR-based drug discovery drug discovery pipeline. Conclusion High-content screening continues to reshape GPCR drug discovery, offering richer biological Image-based high-content screening in drug discovery. Drug Discov Today. 2020.  Way GP et al.

Introduction Dopamine receptors are G-protein-coupled receptors (GPCRs), which have 5 subtypes -D1-5. depression, schizophrenia and Parkinson’s disease. [1,2] Several dopamine ligands have been approved as drugs Therefore, both assays can be used for fundamental D3 receptor-ligand binding studies as well as for drug methods can increase the quality and quantity of both fundamental receptor research and high-throughput drug Current Drug Treatments Targeting Dopamine D3 Receptor.

But Sokhom Pin stayed loyal to GPCRs , even when big pharma turned its gaze to other targets like kinases Riding the GPCR Rollercoaster Early in his career at DuPont and BMS, GPCRs were red hot. “Companies started shutting down neuroscience and GPCR programs. But I stayed,” Sokhom said. The Payoff of Staying Focused Today, GPCRs are making a comeback in popularity. drug discovery , G protein-coupled receptors , GPCR webinar series , GPCR scientist network , GPCR research

GPCRs Re-Enter the Story — Not as Theory, but as Tools GPCRs have always been powerful drug targets — yet challenging to drug. The “Aha” Moment — Ten Years in the Making Many discoveries unfold slowly — dozens of experiments that proved essential to discovery. Emerging direction: Peptide–drug conjugates for precision targeting.

GPCR Allosteric Modulators as Novel Intracellular Molecular Glues Classic models explain biased signaling Reserve your spot ➤ iPSC-Derived Systems for GPCR Signaling and Translation Heterologous systems such From the Masterclass Library Premium Members also have access to Decoding Drug Action with Dr. GPCR Dr. GPCR brings together scientists working across GPCR biology, pharmacology, and drug discovery to examine

A central question of GPCR drug discovery is to understand what determines the agonism or antagonism small changes to the ligands that invert their pharmacological activity and thus helps to guide the drug discovery process. This approach can be readily applied to any drug target." Read more at the source #DrGPCR #GPCR #IndustryNews

how kinetics shape drug action, and how all of it translates into programs. Sam Hoare  — How Signaling Kinetics Shapes GPCR Drug Action. May 14. Learn more about Live Masterclasses ➤ Partner Webinars Eurofins DiscoverX (Dr. GPCR community gathers in person next week. GPCRs Targeted Drug Discovery Summit  — April 28–30. GPCR Dr. GPCR is the intelligence and community for GPCR scientists.

Course Schedule and Details Every Thursday at 10 am EST Principles of Pharmacology in Drug Discovery Principles of Pharmacology in Drug Discovery II - Advanced Methods for the Optimization of Candidate drug discovery. in drug discovery October 2024 | Biologics US 2024 October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry Director GPCR Drug Discovery Biologist Post-Doctoral Scientist- Molecular Pharmacology (FDE) Join Dr.

. _________________ Keyword Cloud: GPCR research community , chronic pain , GPCR drug discovery , GPCR

research and drug discovery. Rational Drug Design One immediate application of this research lies in rational drug design . For example, orthosteric drug design —in which drugs bind to the receptor’s primary active site—can now Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery. Dr. GPCR Ecosystem; Dr. GPCR Ecosystem. https://www.ecosystem.drgpcr.com/post/decoding-gpcr-function-the-role-of-mutagenesis-in-rational-drug-discovery